E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/29/2022 in the Prospect News Distressed Debt Daily.

Mallinckrodt prepares for effective date of May 11

Chicago, April 29 – The effective date, based on the day the Chapter 11 plan conditions are expected to be satisfied for Mallinckrodt plc’s case, is now set for May 11.

The company is preparing its exit financing for a $900 million term loan B with commitments due on May 10, as separately reported by Prospect News.

The amended scheme has been approved by order of the High Court, according to an order dated April 27 and posted Friday.

The company’s Chapter 11 plan was aimed at reducing the company’s total debt by around $1.3 billion.

In the United States, the plan was approved in February.

The company needed to complete examinership proceedings in Ireland for the plan to be effective.

Mallinckrodt is a Dublin-based developer, manufacturer, marketer and distributor of specialty pharmaceutical products and therapies. The company filed Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware on Oct. 12, 2020 under case number 20-12522.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.